Pulmonary Embolism

Clinical Trial Finder

Many patients with pulmonary embolism are interested in participating in the latest research regarding their condition. This Clinical Trial Finder can help you—or a loved one—easily find ongoing cardiovascular clinical research trials for which you might qualify. This list is a service of the U.S. National Institutes of Health called clinicaltrials.gov, a database of publicly and privately supported clinical studies.

Simply click on the trial below that interests you to learn how you might participate.

Correlation Between Reticulated Platelets and Major Adverse Cardiac and Cerebrovascular Events After Noncardiac Surgery

Conditions:   Cardiac Death;   Congestive Heart Failure;   Angina Pectoris;   Stroke;   Pulmonary Embolism;   Deep Vein Thrombosis
Sponsor:   Technische Universität München
Recruiting - verified April 2014

High Intensity Physiotherapy for Hip Fractures

Condition:   Hip Fractures
Interventions:   Other: Intensive physiotherapy;   Other: Usual Care
Sponsor:   The Alfred
Recruiting - verified April 2014

Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)

Conditions:   Pulmonary Embolism;   Thromboembolism;   Thrombosis;   Venous Thrombosis;   Venous Thromboembolism
Interventions:   Drug: BAY 59-7939;   Drug: BAY 59-7939;   Drug: ASA
Sponsor:   Bayer
Recruiting - verified April 2014

GLORIA-AF Registry Program (Phase II/III)

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2014

GLORIA-AF Registry Program (Phase II/III - EU/EEA Member States)

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2014

Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer

Condition:   Prostate Cancer
Interventions:   Drug: bicalutamide;   Drug: buserelin;   Drug: flutamide;   Drug: goserelin acetate;   Drug: leuprolide acetate;   Drug: orteronel;   Drug: triptorelin
Sponsors:   Radiation Therapy Oncology Group;   National Cancer Institute (NCI)
Recruiting - verified April 2014

GLORIA-AF Registry Program - Second and Third Phases

Conditions:   Stroke;   Atrial Fibrillation
Sponsor:   Boehringer Ingelheim
Recruiting - verified April 2014

Dose Adjusting Enoxaparin Thromboprophylaxis Dosage According to Anti-factor Xa Plasma Levels Improve Pregnancy Outcome

Conditions:   Fetal Demise;   Fetal Growth Restriction;   Preeclampsia;   Abruptio Placentae;   Thromboembolism
Intervention:   Drug: enoxaparin
Sponsor:   HaEmek Medical Center, Israel
Recruiting - verified March 2013

A Study of Dalteparin Prophylaxis in High-Risk Ambulatory Cancer Patients

Conditions:   Venous Thromboembolism;   Pulmonary Embolism
Intervention:   Drug: dalteparin injection
Sponsors:   University of Rochester;   National Heart, Lung, and Blood Institute (NHLBI);   Eisai Inc.
Active, not recruiting - verified April 2014

Tranexamic Acid in Urologic Surgery

Conditions:   Bleeding;   Prostatectomy
Interventions:   Drug: Tranexamic Acid;   Drug: Placebo
Sponsor:   Università Vita-Salute San Raffaele
Completed - verified July 2010

Genetic Risk Factors Associated With Antiphospholipid Antibody Syndrome

Condition:   Antiphospholipid Syndrome
Sponsor:   Duke University
Recruiting - verified February 2014

Deep Vein Thrombosis (DVT) Prevention in Total Hip Arthroplasty: Continuous Enhanced Circulation Therapy (CECT) Versus Low Molecular Weight Heparin (LMWH)

Conditions:   Deep Vein Thrombosis of Lower Limb;   Pulmonary Embolism (PE);   Bleeding
Interventions:   Device: ActiveCare CECT device;   Drug: Enoxaparin
Sponsor:   Medical Compression Systems
Completed - verified February 2010

Nurses' Health Study (Cardiovascular Component)

Conditions:   Cardiovascular Diseases;   Diabetes Mellitus;   Coronary Disease;   Heart Diseases;   Cerebrovascular Accident;   Pulmonary Embolism;   Angina Pectoris;   Myocardial Infarction;   Menopause;   Postmenopause
Sponsors:   Brigham and Women's Hospital;   National Heart, Lung, and Blood Institute (NHLBI)
Completed - verified April 2014

Get CardioSmart

You're Invited